| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |